Kadowaki, T., Wang, G., Rosenstock, J., Yabe, D., Peng, Y., Kanasaki, K., . . . Marx, N. (2020). Effect of linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulfonylurea glimepiride on cardiovascular outcomes in Asians with type 2 diabetes: Subgroup analysis of the randomized CAROLINA® trial. Diabetol Int.
Citação norma ChicagoKadowaki, Takashi, et al. "Effect of Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Compared With the Sulfonylurea Glimepiride On Cardiovascular Outcomes in Asians With Type 2 Diabetes: Subgroup Analysis of the Randomized CAROLINA® Trial." Diabetol Int 2020.
Citação norma MLAKadowaki, Takashi, et al. "Effect of Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Compared With the Sulfonylurea Glimepiride On Cardiovascular Outcomes in Asians With Type 2 Diabetes: Subgroup Analysis of the Randomized CAROLINA® Trial." Diabetol Int 2020.